Open Access - Five (5) Reviews on the Vaginal Microbiome
NOW AVAILABLE FOR FREE
Understanding how the microorganisms that inhabit the vagina interact with each other and with the host is fundamental in the diagnosis, treatment, and prevention of vulvovaginal disease. The ISSVD is proud to announce the publication of 5 comprehensive manuscripts that revealed advances on the role of the microbiota in lower genital tract infection in women of all ages.

These manuscripts are preceded by a commentary by Prof. Jack Sobel, Dean and Distinguished Professor of the Wayne State University School of Medicine
Open Access Now Available at the
Journal of Lower Genital Tract Disease
Lower Genital Tract Microbiome — A Work in Progress
Lower Genital Tract Microbiome — A Work in Progress 
(View Article)
The Vaginal Microbiome: I. Research Development, Lexicon, Defining “Normal” and the Dynamics Throughout Women's Lives
The Vaginal Microbiome:
I. Research Development, Lexicon, Defining “Normal” and the Dynamics Throughout Women's Lives
(View Article)
The Vaginal Microbiome: II. Vaginal Dysbiotic Conditions
The Vaginal Microbiome:
II. Vaginal Dysbiotic Conditions
(View Article)
The Vaginal Microbiome: III. The Vaginal Microbiome in Various Urogenital Disorders
The Vaginal Microbiome:
III. The Vaginal Microbiome in Various Urogenital Disorders
(View Article)
The Vaginal Microbiome:
IV. The Role of Vaginal Microbiome in Reproduction and in Gynecologic Cancers
(View Article)
The Vaginal Microbiome: V. Therapeutic Modalities of Vaginal Microbiome Engineering and Research Challenges
The Vaginal Microbiome:
V. Therapeutic Modalities of Vaginal Microbiome Engineering and Research Challenges
(View Article)
ISSVD Member Resource Library
Additional Content Available 
You can get access to more exclusive content by becoming a member of the ISSVD. In our members-only resource library, you can stay updated on the latest protocols and resources. 
Become a member
SPECIAL THANKS TO

Ahinoam Lev-Sagie MD for leading this project, as well to the rest of the team (Hans Verstraelen MD, MPH, PhD; Pedro Vieira-Baptista MD, Francesco de Seta MD, Gary Ventolini MD, FACOG and Risa Lonnee-Hoffmann MD, PhD.)